Xigen

Switzerland
Epalinges, Vaud, Switzerland, 1066

Company profile

Xigen company profile

Xigen SA is a private Swiss biopharmaceutical company founded in 2002 as a spin-off from the University Hospital of Lausanne (CHUV) in Switzerland. Dr. Christophe Bonny, CEO and co-founder, is a renowned molecular biologist with over a decade's research expertise on intracellular peptides and signalling.

Business identity

Contact email
[email protected]
Phone number
41213211081
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2002-01-01, Year

Headquarters

Postal code
1066
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$41M
Last funding
Series B / $20M / 2009-11-20
Last equity funding
Series B / $20M
Investors
3
Lead investors
1
Founders
2
Articles
2

Founders and investors

Founders

Christophe BonnyPeter Harboe Schmidt

Lead investors

Tilocor Life Science

Investors

Initiative CapitalTilocor Life ScienceVI Partners